Long-term antiviral therapy sustains HBsAg decline, increases HBV RNA negativity and enhances the proportion of patients achieving functional cure in chronic hepatitis B
Long-term antiviral therapy sustains HBsAg decline, increases HBV RNA negativity and enhances the proportion of patients achieving functional cure in chronic hepatitis B. // Annals of Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S1665268126000335?dgcid=rss_sd_all
Long-term antiviral therapy sustains HBsAg decline, increases HBV RNA negativity and enhances the proportion of patients achieving functional cure in chronic hepatitis B. Annals of Hepatology. https://www.sciencedirect.com/science/article/pii/S1665268126000335?dgcid=rss_sd_all
“Long-term antiviral therapy sustains HBsAg decline, increases HBV RNA negativity and enhances the proportion of patients achieving functional cure in chronic hepatitis B.” Annals of Hepatology.
@article{article88422,
title = {Long-term antiviral therapy sustains HBsAg decline, increases HBV RNA negativity and enhances the proportion of patients achieving functional cure in chronic hepatitis B},
journal = {Annals of Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S1665268126000335?dgcid=rss_sd_all}
}